China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)
600062.SS on Shanghai Stock Exchange
12.56CNY
2:11am GMT
12.56CNY
2:11am GMT
Change (% chg)
¥0.01 (+0.08%)
¥0.01 (+0.08%)
Prev Close
¥12.55
¥12.55
Open
¥12.58
¥12.58
Day's High
¥12.64
¥12.64
Day's Low
¥12.45
¥12.45
Volume
3,942,197
3,942,197
Avg. Vol
4,891,777
4,891,777
52-wk High
¥22.73
¥22.73
52-wk Low
¥12.40
¥12.40
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.16 | December | 11 Dec 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 4 | 5 | 5 | 5 |
| (2) OUTPERFORM | 5 | 5 | 5 | 5 |
| (3) HOLD | 1 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.70 | 1.50 | 1.50 | 1.50 |
Consensus Estimates Analysis
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 2 | 1,863.89 | 2,107.00 | 1,620.79 | 1,704.88 |
| Quarter Ending Mar-19 | 1 | 1,656.34 | 1,656.34 | 1,656.34 | 1,400.94 |
| Year Ending Dec-18 | 9 | 7,660.46 | 8,416.00 | 6,871.53 | 6,747.28 |
| Year Ending Dec-19 | 8 | 8,970.42 | 9,986.00 | 8,173.39 | 7,415.42 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 1 | 0.16 | 0.16 | 0.16 | 0.33 |
| Quarter Ending Mar-19 | 1 | 0.22 | 0.22 | 0.22 | 0.30 |
| Year Ending Dec-18 | 9 | 0.95 | 1.00 | 0.92 | 1.00 |
| Year Ending Dec-19 | 8 | 1.13 | 1.29 | 1.06 | 1.15 |
Historical Surprises
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Sep-18 | 1,620.79 | 2,221.83 | 601.04 | 37.08 |
| Quarter Ending Jun-18 | 1,923.67 | 1,949.88 | 26.21 | 1.36 |
| Quarter Ending Mar-18 | 1,442.75 | 2,137.80 | 695.05 | 48.18 |
| Quarter Ending Dec-17 | 1,067.61 | 1,665.81 | 598.20 | 56.03 |
| Quarter Ending Sep-17 | 1,403.22 | 1,680.15 | 276.93 | 19.74 |
| Earnings (per share) | ||||
| Quarter Ending Sep-18 | 0.16 | 0.25 | 0.09 | 52.38 |
| Quarter Ending Jun-18 | 0.27 | 0.27 | 0.01 | 1.96 |
| Quarter Ending Mar-18 | 0.20 | 0.29 | 0.09 | 44.58 |
| Quarter Ending Dec-17 | 0.31 | 0.11 | 0.20 | 63.78 |
| Quarter Ending Sep-17 | 0.22 | 0.20 | 0.03 | 12.09 |
Consensus Estimates Trend
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 1,863.89 | 1,863.89 | 1,620.79 | 1,620.79 | 1,704.88 |
| Quarter Ending Mar-19 | 1,656.34 | 1,656.34 | 1,656.34 | 1,656.34 | 1,400.94 |
| Year Ending Dec-18 | 7,660.46 | 7,660.46 | 7,566.02 | 7,490.57 | 6,747.28 |
| Year Ending Dec-19 | 8,970.42 | 8,970.42 | 8,832.62 | 8,656.29 | 7,415.42 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 0.16 | 0.16 | 0.16 | 0.16 | 0.33 |
| Quarter Ending Mar-19 | 0.22 | 0.22 | 0.22 | 0.22 | 0.30 |
| Year Ending Dec-18 | 0.95 | 0.95 | 0.95 | 0.95 | 1.00 |
| Year Ending Dec-19 | 1.13 | 1.13 | 1.11 | 1.11 | 1.15 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Dec-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Mar-19 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Dec-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Mar-19 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
Earnings vs. 
Estimates